Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Novel poly(ADP-ribose) polymerase-1 inhibitorsDerek Dunn, Jean Husten, Mark A Ator, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2006
Novel poly(ADP-ribose) polymerase-1 inhibitorsDerek Dunn, Jean Husten, Mark A Ator, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2012
Serendipity in discovery of proteasome inhibitorsDerek Dunn, Mohamed Iqbal, Jean Husten, et al.
Chemical Biology & Drug Design|May 18, 2013
Serendipitous discovery of a prodrug of a PARP-1 inhibitorDerek Dunn, Jean Husten, Lisa D Aimone, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2005
Synthesis and structure-activity relationships of novel pyrrolocarbazole lactam analogs as potent and cell-permeable inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)Gregory J Wells, Ron Bihovsky, Robert L Hudkins, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Synthesis and structure-activity relationships of novel poly(ADP-ribose) polymerase-1 inhibitorsMing Tao, Chung Ho Park, Ron Bihovsky, et al.
Bioorganic & Medicinal Chemistry|March 2, 2012
Proteasome inhibitors for cancer therapyMohamed Iqbal, Patricia A Messina McLaughlin, Derek Dunn, et al.
Allergy, Asthma & Immunology Research|January 21, 2019
Higher Binding Affinity and in vitro Potency of Reslizumab for Interleukin-5 Compared With MepolizumabMark Liddament, Jean Husten, Tanya Estephan, et al.
Bioanalysis|March 22, 2021
Development of a Meso Scale Discovery ligand-binding assay for measurement of free (drug-unbound) target in nonhuman primate serumYun Liu, Ronald Robinson, Thao Ung, et al.
Assay and Drug Development Technologies|June 14, 2012
Comparison of LanthaScreen Eu kinase binding assay and surface plasmon resonance method in elucidating the binding kinetics of focal adhesion kinase inhibitorsJennifer L Mason, Chrysanthe Spais, Jean Husten, et al.
Pageof 2